Brief: Egetis Therapeutics H1 Adjusted EPS SEK -0.5
Aug 22 (Reuters) - Egetis Therapeutics H1 revenue SEK 25.9 million. * H1 net income SEK -146.9 million
Aug 22 (Reuters) - Egetis Therapeutics H1 revenue SEK 25.9 million. * H1 net income SEK -146.9 million